Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Vivos Therapeutics Inc (VVOS)

Vivos Therapeutics Inc (VVOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Vivos Therapeutics Inc 7921 SOUTHPARK PLAZA SUITE 210 LITTLETON CO 80120 USA

www.vivos.com Employees: 109 P: 866-908-4867

Sector:

Medical

Description:

Vivos Therapeutics Inc. is a medical technology company. It engages in the development and commercialization of technology solutions for patients with sleep disordered breathing comprising mild-to-moderate obstructive sleep apnea. Vivos Therapeutics Inc. is based in Highlands Ranch, Colorado.

Key Statistics

Overview:

Market Capitalization, $K 19,536
Enterprise Value, $K 13,276
Shares Outstanding, K 9,438
Float, K 9,240
% Float 97.90%
Short Interest, K 290
Short Float 3.23%
Days to Cover 2.17
Short Volume Ratio 0.63
% of Insider Shareholders 2.10%
% of Institutional Shareholders 26.35%

Financials:

Annual Sales, $ 15,030 K
Annual Net Income, $ -11,140 K
Last Quarter Sales, $ 6,780 K
Last Quarter Net Income, $ -5,400 K
EBIT, $ -15,310 K
EBITDA, $ -14,730 K

Growth:

1-Year Return -65.21%
3-Year Return -93.91%
5-Year Return -98.76%
5-Year Revenue Growth 31.96%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.49 on 11/19/25
Next Earnings Date 03/30/26
Earnings Per Share ttm -1.77
EPS Growth vs. Prev Qtr 10.91%
EPS Growth vs. Prev Year -22.50%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-25 on 10/27/23

VVOS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -351.28%
Return-on-Assets % -87.44%
Profit Margin % -74.12%
Debt/Equity 3.45
Price/Sales 1.07
Price/Cash Flow N/A
Price/Book 6.19
Book Value/Share 0.34
Interest Coverage -0.43
60-Month Beta 6.89
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar